Mr. Chair, thank you.
First of all, in my reference to the increasing trends we're seeing in pharmaceuticals, prescription drugs, a lot of that is just what we see in terms of investigations. In new cases coming before public prosecutions, etc., we see an increase. Those are the trends I'm talking about.
Mr. Chair, a number of studies referenced in earlier submissions, by Health Canada, by other members, are clear. We see a growing trend in this. What I'm suggesting is that we don't see anything different, at least from a public safety perspective, to counter that trend. With respect to systemic abuse, I would say that I'm from the law enforcement community, but I know Health Canada—and Health Canada was here last week—was talking about a number of systems they're attempting to put into place.
I am not the best placed to comment on an upfront, systematic approach to this. What I can speak to is that in addressing some of the law enforcement supply-reduction concerns, we're moving forward, and we think that, ultimately, take-back days and those types of initiatives can have an effect. I know that's not a systematic system such as you're talking about, but in terms of addressing some of the law enforcement concerns, we think that's an appropriate way to intercept some of the supply.